Estazolam: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Estazolam. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Somnolence | 42% |
| Headache | 27% |
| Asthenia | 11% |
| Nervousness | 11% |
| Hypokinesia | 8% |
| Dizziness | 7% |
| Malaise | 5% |
| Nausea | 5% |
| Cold symptoms | 5% |
| Coordination abnormal | 4% |
| Lower extremity pain | 3% |
| Hangover | 3% |
| Depression | 3% |
| Back pain | 2% |
| Body pain | 2% |
| Abdominal pain | 2% |
| Dyspepsia | 2% |
| Confusion | 2% |
| Dream abnormal | 2% |
| Thinking abnormal | 2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Estazolam tablets are indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Both out-patient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see CLINICAL PHARMACOLOGY ). Because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended. Since insomnia may be a symptom of several other disorders, the possibility that the complaint may be related to a condition for which there is a more specific treatment should be considered. There is evidence to support the ability of estazolam to enhance the duration and quality of sleep for intervals up to 12 weeks (see CLINICAL PHARMACOLOGY ).
Medical disclaimer: Always consult a qualified healthcare professional about any medication.